Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-06-14 @ 9:48 AM
Study NCT ID:
NCT06281834
Status:
RECRUITING
Last Update Posted:
2024-12-24
First Post:
2024-02-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
Sponsor:
Organization: